Presentation Information
[O8-02]Antibody-Dependent Enhancement in Dengue Vaccine Evaluations: Key Insights
*Kouichi Morita1,2, Dengue Vaccine Development Group2 (1. Nagasaki University, Dejima Infectious Disease Research Alliance (DIDA) (Japan), 2. Nagasaki University, Vaccine Research and Development Center (VRDC) (Japan))

Comment
To browse or post comments, you must log in.Log in